Patents Assigned to Rosetta Genomics Inc.
  • Patent number: 8207316
    Abstract: The present invention relates to a group of noel viral RNA regulatory genes, here identified as “viral genomic address messenger genes”or “VGAM genes”, and as “Viral genomic record”or “VGR genes”. VGAM genes selectively inhibit translation of known host target genes, and are believed to represent a pervasive viral attack mechanism. VGR genes encode an “operon”-like cluster of VGAM genes. VGAM and viral VGR genes may therefore be useful in diagnosing, preventing and treating viral disease. Several nucleic acid molecules are provided respectively encoding several VGAM genes, as are vectors and probes, both comprising the nucleic acid molecules, and methods and systems for detecting VGAM genes, and for counteracting their activity.
    Type: Grant
    Filed: October 30, 2003
    Date of Patent: June 26, 2012
    Assignee: Rosetta Genomics, Inc.
    Inventor: Itzhak Bentwich
  • Patent number: 8084598
    Abstract: The present invention relates to a first group of novel oligonucleotides, here identified as genomic address messenger or GAM oligonucleotides, and a second group of novel operon-like polynucleotides, here identified as genomic record or GR polynucleotides. GAM oligonucleotides selectively inhibit translation of known target genes, many of which are known to be involved in various diseases. Nucleic acid molecules are provided respectively encoding 2147 GAM oligonucleotides, and 313 GR polynucleotides as are vectors and probes both comprising the nucleic acid molecules, and methods and systems for detecting GAM oligonucleotides and GR polynucleotide and specific functions and utilities thereof, for detecting expression of GAM oligonucleotides and GR polynucleotides and for selectively enhancing and selectively inhibiting translation of the respective target genes thereof.
    Type: Grant
    Filed: January 29, 2004
    Date of Patent: December 27, 2011
    Assignee: Rosetta Genomics Inc.
    Inventor: Itzhak Bentwich
  • Patent number: 7790867
    Abstract: The present invention relates to a group of viral RNA regulatory genes, here identified as “viral genomic address messenger genes” or “VGAM genes”, and as “genomic record” or “GR” genes. VGAM genes selectively inhibit translation of known host target genes, and are believed to represent a pervasive viral attack mechanism. GR genes encode an operon-like cluster of VGAM genes. VGAM and viral GR genes may therefore be useful in diagnosing, preventing and treating viral disease. Several nucleic acid molecules are provided respectively encoding several VGAM genes, as are vectors and probes, both comprising the nucleic acid molecules, and methods and systems for detecting VGAM genes, and for counteracting their activity.
    Type: Grant
    Filed: August 28, 2003
    Date of Patent: September 7, 2010
    Assignee: Rosetta Genomics Inc.
    Inventor: Itzhak Bentwich
  • Patent number: 7709616
    Abstract: Described herein are polynucleotides associated with prostate and lung cancer. The polynucleotides are miRNAs and miRNA precursors. Related methods and compositions that can be used for diagnosis, prognosis, and treatment of those medical conditions are disclosed. Also described herein are methods that can be used to identify modulators of prostate and lung cancer.
    Type: Grant
    Filed: May 16, 2005
    Date of Patent: May 4, 2010
    Assignee: Rosetta Genomics Inc.
    Inventors: Itzhak Bentwich, Amir Avniel, Yael Karov, Ranit Aharonov